Opioid Supply Levels Decline in Most States
Maine had the greatest decline at 25% compared with the national average of 11%.
CMS Expands Benefit Flexibilities in Medicare Advantage
Earlier this year, the administration granted Medicare Advantage plans greater flexibility to target benefit designs for individuals with certain high-risk health conditions. These changes are expected to position the program for continued growth.
More than 1 in 5 Medicare Cancer Patients Receive Care from Oncology Care Model Doctors
More than 25% of patients with breast and lung cancers have been treated by a participating Oncology Care Model doctor. Participation trends could accelerate the transformation of treatment for some cancers, according to Avalere experts.
Readmission Rates Are 6 Times Higher for Some Conditions in Medicare’s New Bundled Payment Program
As the deadline approaches for providers to make decisions on their participation in BPCI Advanced, Avalere analysis shows that certain conditions may provide greater opportunity for success.
Trump Administration Releases Drug Pricing Blueprint
The Department of Health and Human Services is seeking public input on a variety of proposals related to drug costs, providing stakeholders with an unprecedented opportunity to shape the administration's drug pricing policies.
State-Level Policies Can Play Key Role in Improving Adult Immunization Rates
States can pursue various policy opportunities to encourage vaccination and increase access to vaccines.
Emerging Opportunities to Drive Adult Immunization Through Quality
Quality measurement in the adult vaccine space has evolved rapidly. Recent advancements continue to propel efforts to drive adult immunization uptake.
The Future of the Center for Medicare & Medicaid Innovation
On April 24, 2018, Avalere experts were joined by Aledade CEO, Farzad Mostashari, MD, to discuss the latest developments coming out of the Center for Medicare & Medicaid Innovation (CMMI).
The Opioid Crisis: An Ongoing Legislative Priority
The House and Senate are advancing legislative packages aimed at mitigating the crisis.
Recent Proposals by the Administration Hint at Areas of Focus for Upcoming Drug Pricing Plan
President Trump is expected to announce a drug pricing plan in the coming weeks; signals from the White House indicate potential alignment around several priority policies.
Patient Out-of-Pocket Assistance in Medicare Part D: Direct and Indirect Healthcare Savings
Avalere examines the effect of foundation-sponsored financial assistance on out-of-pocket costs and federal spending.
The Future of CMMI: Where Do We Go from Here?
Avalere experts are joined by Aledade CEO, Farzad Mostashari, MD, discussing the latest developments coming out of the Center for Medicare & Medicaid Innovation (CMMI).
Policymakers Seek to Balance Patient Information Sharing with Privacy Protections
Coordinated information sharing can facilitate the delivery of integrated care to patients using both physical and behavioral health services.
Registries Continue to Give More Opportunities for Clinicians to Meet Reporting Requirements
The number of CMS-approved Qualified Clinical Data Registries grew by 40% in 2018, allowing specialties to have more opportunities to report on meaningful quality measures.
Limits on Opioid Prescriptions Are Becoming More Widespread
In response to the concern that overprescribing is a driver of the opioid crisis, payers are limiting opioid fills as one solution.
CMS Gives More Flexibility to States When Regulating Health Insurance
The Centers for Medicare & Medicaid Services released the final Notice of Benefit and Payment Parameters (NBPP) for the 2019 plan year.
Two-Year Countdown Begins for FDA “Roll-Over” of Biologics Currently Regulated as Drugs
In just two years, on March 23, 2020, biologics currently regulated as drugs will transition to being regulated as biologics. Many aspects of how FDA will implement this transition have yet to be established.
E2 – Real-World Evidence: Is It a Game Changer for the FDA?
Episode 2 of our discussion covers why the FDA is so interested in real-world evidence and how they are approaching it.
Adapting to Medicaid Changes and Trends in 2018
On March 6, Avalere experts came together to discuss the latest Medicaid developments.
Medicaid: Adapt to the Changes
Avalere experts discuss an evolving Medicaid program supported by a new administration and novel state approaches.